As of March 1st, 2025, Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL, our trusted distributor of ๐๐ง๐๐จ๐๐ซ๐๐๐ข๐๐ญยฎ and ๐๐ซ๐จ๐ฅ๐๐ซ๐ข๐ฌยฎ in Italy.
This strategic step strengthens our presence in the Italian market and reaffirms our commitment to providing innovative oncology solutions to patients and healthcare professionals. We look forward to this new chapter and the opportunities it brings!
#EurobioScientific #Quimark #Oncology #EndoPredict #Prolaris
- Products
- Mega-Menu
-
Transplantation
The group produces reagents and software for transplant matching, chimerism monitoring and culture media for cornea graft transplants.
-
Oncology
Eurobio Scientific manufactures prognostic genomic tests for breast cancer and prostate cancer.
-
Infectious Diseases
The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions
-
Life Sciences
To support the research and development field, Eurobio Scientific has a broad portfolio in Life Science products including cell culture media and quality controls.
-
Quality Control
The controls for auto-immunity and allergy are multi-analyte controls, which offers a the possibility of testing different analytes in parallel by using only one control.
-
- Mega-Menu
- About Us
- Investors
- Join Us

